We are independent & ad-supported. We may earn a commission for purchases made through our links.

Advertiser Disclosure

Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.

How We Make Money

We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently from our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.

How Effective Is Rivaroxaban for Atrial Fibrillation?

Mary McMahon
Updated May 17, 2024
Our promise to you
WiseGeek is dedicated to creating trustworthy, high-quality content that always prioritizes transparency, integrity, and inclusivity above all else. Our ensure that our content creation and review process includes rigorous fact-checking, evidence-based, and continual updates to ensure accuracy and reliability.

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

Editorial Standards

At WiseGeek, we are committed to creating content that you can trust. Our editorial process is designed to ensure that every piece of content we publish is accurate, reliable, and informative.

Our team of experienced writers and editors follows a strict set of guidelines to ensure the highest quality content. We conduct thorough research, fact-check all information, and rely on credible sources to back up our claims. Our content is reviewed by subject matter experts to ensure accuracy and clarity.

We believe in transparency and maintain editorial independence from our advertisers. Our team does not receive direct compensation from advertisers, allowing us to create unbiased content that prioritizes your interests.

Rivaroxaban for atrial fibrillation can be highly effective, causing fewer side effects and requiring less need for monitoring. This medication does not actually treat atrial fibrillation directly, but instead reduces the risk of stroke in patients who have this condition. The historic gold standard for managing stroke risk in atrial fibrillation patients has been the anticoagulant warfarin, which can be dangerous if the patient is not carefully monitored throughout treatment. An alternative that is safer and easier to administer carries a number of advantages.

In people with atrial fibrillation, where the heartbeats are irregular, the stroke risk can be significantly increased without the help of an anticoagulant. Rivaroxaban works by interrupting the coagulation cascade that normally causes clotting. Patients can take a single daily pill and experience protection for 24 hours. Unlike patients on warfarin, they do not need regular blood tests and examinations to check on clotting status and determine if the dosage is correct.

Clinical trials on rivaroxaban for atrial fibrillation demonstrated that it could be safer and more effective for stroke prevention. This included studies in patients with serious illnesses, who can be more difficult to treat because of the risk of medication and disease interactions. Based on this information, the US Food and Drug Administration approved rivaroxaban for atrial fibrillation, indicating that it supported this use, and regulators in other nations have followed suit.

Alternative therapies to prevent stroke can be important. If a patient doesn’t respond well to one medication, having another, like rivaroxaban for atrial fibrillation, means that the patient won’t be stuck without viable options. Doctors can work with their patients to find the best treatment option and adjust the dosage to find the patient’s comfort level, the point where a drug is effective with a low chance of side effects. Patients who later develop drug reactions can discuss available alternatives to see what kinds of options might be considered.

While using rivaroxaban for atrial fibrillation, it is important for patients to attend their regularly scheduled medical appointments. These provide an opportunity to check for serious side affects, assess heart health, and determine if the patient has any other medical issues that need to be addressed. People should also call their medical practitioners if they experience problems that might indicate the medication is not working or a bad reaction is occurring. It is also advisable to carry a medic alert card with information about the anticoagulant, as this may be important for first responders to have in an emergency.

WiseGeek is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.
Mary McMahon
By Mary McMahon

Ever since she began contributing to the site several years ago, Mary has embraced the exciting challenge of being a WiseGeek researcher and writer. Mary has a liberal arts degree from Goddard College and spends her free time reading, cooking, and exploring the great outdoors.

Discussion Comments

Mary McMahon

Mary McMahon

Ever since she began contributing to the site several years ago, Mary has embraced the exciting challenge of being a...

Learn more
WiseGeek, in your inbox

Our latest articles, guides, and more, delivered daily.

WiseGeek, in your inbox

Our latest articles, guides, and more, delivered daily.